These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Role of the cholecystokinin system in anxiolytic activity of dipeptide GB-115. Kolik LG; Gudasheva TA; Seredenin SB Bull Exp Biol Med; 2012 Oct; 153(6):851-4. PubMed ID: 23113301 [TBL] [Abstract][Full Text] [Related]
3. [Effect of GB-115 dipeptide on anxiety in rats with model benzodiazepine withdrawal syndrome]. Kolik LG; Kadnikov IA; Zhukov VN; Gudasheva TA; Seredenin SB Eksp Klin Farmakol; 2011; 74(10):7-11. PubMed ID: 22238979 [TBL] [Abstract][Full Text] [Related]
4. [Experimental study of antidepressant effects of GB-115 dipeptide]. Kolik LG Eksp Klin Farmakol; 2011; 74(1):3-5. PubMed ID: 21476266 [TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetic study of anxiolytic effects of new cholecystokinin receptor antagonists in animals with different levels of emotionality. Kolik LG; Gudasheva TA; Seredenin SB Bull Exp Biol Med; 2003 May; 135(5):440-4. PubMed ID: 12910281 [TBL] [Abstract][Full Text] [Related]
6. Behavioural pharmacological characteristics of honokiol, an anxiolytic agent present in extracts of Magnolia bark, evaluated by an elevated plus-maze test in mice. Kuribara H; Stavinoha WB; Maruyama Y J Pharm Pharmacol; 1998 Jul; 50(7):819-26. PubMed ID: 9720634 [TBL] [Abstract][Full Text] [Related]
7. [Design and synthesis of cholecystokinin-4 dipeptide analogues with anxiolytic and anxiogenic activities]. Gudasheva TA; Kir'ianova EP; Kolik LG; Konstantinopol'skiĭ MA; Seredenin SB Bioorg Khim; 2007; 33(4):413-20. PubMed ID: 17886432 [TBL] [Abstract][Full Text] [Related]
9. Protective and therapeutic effects of glyprolines in psychoemotional stress induced by cholecystokinin-4 injection. Edeeva SE; Kopylova GN; Bakaeva ZV; Samona GE; Umarova BA; Guseva AA Bull Exp Biol Med; 2008 Mar; 145(3):302-6. PubMed ID: 19039929 [TBL] [Abstract][Full Text] [Related]
10. Analysis of strain difference in behavior to Cholecystokinin (CCK) receptor mediated drugs in PVG hooded and Sprague-Dawley rats using elevated plus-maze test apparatus. Farook JM; Zhu YZ; Wang Q; Moochhala SM; Lee L; Wong PT Neurosci Lett; 2004 Apr; 358(3):215-9. PubMed ID: 15039119 [TBL] [Abstract][Full Text] [Related]
11. BOC-CCK-4, CCK(B)receptor agonist, antagonizes anxiolytic-like action of morphine in elevated plus-maze. Kõks S; Soosaar A; Võikar V; Bourin M; Vasar E Neuropeptides; 1999 Feb; 33(1):63-9. PubMed ID: 10657473 [TBL] [Abstract][Full Text] [Related]
12. [Investigation of the effects of mexidol in escapable and inescapable emotional stress in inbred BALB/C and C57BL/6 mice]. Kravtsova OIu; Voronina TA; Sariev AK Eksp Klin Farmakol; 2004; 67(6):8-11. PubMed ID: 15707005 [TBL] [Abstract][Full Text] [Related]